News And Announcements
Carr's beats its expectations as FY profit and revenue rise
Agriculture and engineering group Carr's reported a jump in full-year profit and revenue on Monday thanks to a strong performance in UK agriculture, with growth across all areas.
Hibernia adds to Newlands Cross holdings in Dublin
Hibernia REIT announced two acquisitions of land at Gateway - Newlands Cross on Monday, taking its total interests in the area to 143. 7 acres.
Mission Marketing offloads BroadCare to Carehome Selection
Mission Marketing has sold its BroadCare business to Carehome Selection - part of the CHS Healthcare - for £4. 4m in cash, it announced on Monday.
RHI Magnesita opens tender offer to minority shareholders
RHI Magnesita updated the market on the integrated tender offer, as well as announced the launch of the offer to minority shareholders, of Magnesita Refratários on Monday.
Chris Fong to head up High Growth Capital
High Growth Capital announced on Monday that Christopher Fong would be appointed as its chief executive officer, conditional on completion of satisfactory due diligence.
Smurfit Kappa included in sustainability index for fifth year running
Smurfit Kappa has been reconfirmed as a member of the Ethibel Sustainability Index for the fifth year in a row, it announced on Monday, which its said demonstrated its continued “best-in-class approach” to sustainability.
SoftBank gets go-ahead for record £16bn mobile flotation
SoftBank is to launch a record-beating stock market flotation, after it won approval to spin out its mobile phone business in a ¥2. 4trn (£16bn) initial public offering.
Takeda to seek investor approval for Shire take-over next month; shares spike
Japan’s Takeda Pharmaceutical has announced it expects to complete its $62bn takeover of Shire Pharmaceuticals in early January, sending shares in the FTSE 100 drugs group higher.
Rio Tinto completes two thirds of buyback
Rio Tinto has completed a A$2. 87bn (US$2. 1bn, £1. 6bn) off-market share buyback to cancel 2. 41% of the group's issued shares.
Tobacco stocks run out of puff over US menthol crackdown
Shares in British American Tobacco went up on smoke on Monday after it emerged the US authorities were considering banning menthol cigarettes.
Dignity profits drop but revenues up in Q3
Funeral provider Dignity posted a drop in profits on Monday as it continues to battle competition in the market.
FOBT delay 'influenced' by industry report
The UK government’s controversial decision to delay until next October a cut in stakes on fixed-odds betting terminals (FOBTs) to £2 from £100 was influenced by secret report commissioned by bookmakers, the Guardian reported on Monday.
Johnston Press surges as DMGT said to plan bid for i newspaper
Johnston Press surged on Monday following reports over the weekend that Daily Mail owner DMGT is planning on bidding for the i newspaper.
Babcock fights back against mystery Boatman
Responding to an attack from a mystery research firm, defence contractor Babcock International insisted its relationship with the Ministry of Defence was "as strong as ever".
Playtech backs full-year expectations
Gambling software company Playtech reiterated its full-year guidance on Monday as it said trading since the end of June has been consistent with expectations at the time of the half-year results in August.
First production at Polymetal's Nezdha expected in Q4 2021
Polymetal International said on Monday that its board has approved the construction of the Nezdha gold project in Siberia following the completion of a feasibility study.
AstraZeneca posts positive results from recent Farxiga trial
AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga (dapagliflozin) on Monday.
Restaurant Group launches £315m rights issue to fund Wagamama deal
The Restaurant Group has launched a fully underwritten £315m rights issue to help fund its £357m acquisition of Wagamama.
Sirius Minerals awards build contract for UK fertliser project
Sirius Minerals said it had extended its tunnelling contract with STRABAG to include engineering, procurement and construction of the fit-out of its 37km underground fertiliser transport system in North East England.
AstraZeneca adds another indication for Lynparza in the US
AstraZeneca, and its partner Merck & Co, announced on Monday that the US Food and Drug Administration has accepted a supplemental New Drug Application (sNDA) for priority review, for the use of Lynparza (olaparib) tablets as a maintenance treatment in patients with newly-diagnosed, BRCA-mutated (BRCAm) advanced ovarian cancer who were in complete or partial response following first-line standard platinum-based chemotherapy.